DYN
Dyne Therapeutics, Inc.
$23.83
+0.99 (+4.33%)
At close · Jul 7
Market Cap
$3.40B
Shares
142,824,687
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-22 | — | |
| 8-K | 2026-06-17 | 2026-06-16 | |
| 8-K | 2026-06-08 | 2026-06-05 | |
| 8-K | 2026-06-03 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-23 | 2026-04-22 | |
| 10-K | 2026-03-02 | 2025-12-31 | |
| 8-K | 2026-03-02 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-23 | 2025-12-22 | |
| 8-K | 2025-12-10 | 2025-12-09 | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-12-08 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-10-02 | 2025-10-01 | |
| 8-K | 2025-08-04 | — | |
| 10-Q | 2025-07-28 | 2025-06-30 | |
| 8-K | 2025-07-28 | — | |
| 8-K | 2025-07-01 | 2025-06-30 | |
| 8-K | 2025-06-30 | 2025-06-27 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-05 | 2025-05-30 | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — | |
| DEF 14A | 2025-04-15 | 2025-05-30 | |
| 8-K | 2025-03-20 | 2025-03-17 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-03 | 2024-08-31 | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-05-24 | 2024-05-22 | |
| 8-K | 2024-05-22 | 2024-05-21 | |
| 8-K | 2024-05-20 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-05-02 | — | |
| DEF 14A | 2024-04-05 | 2024-05-22 | |
| 8-K | 2024-03-25 | 2024-03-21 | |
| 8-K | 2024-03-05 | — | |
| 10-K | 2024-03-05 | 2023-12-31 | |
| 8-K | 2024-01-05 | 2024-01-04 | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2024-01-03 | — |
Showing 1–50 of 91 filings